AnGes Inc
AJW
Company Profile
Business description
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Contact
7-7-15, Saito-asagi
4F, Saito Bio-Incubator
Ibaraki
Osaka567-0085
JPNSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
71
Stocks News & Analysis
stocks
Unwarranted drop in ASX share
Jittery investors misinterpret an audit for an existential crisis.
stocks
After earnings, is Disney stock a buy, a sell, or fairly valued? -
Following the highly anticipated announcement of a new CEO, here’s what we think of Disney.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,281.80 | 97.30 | 1.06% |
| CAC 40 | 8,311.89 | 15.99 | -0.19% |
| DAX 40 | 24,950.28 | 37.57 | -0.15% |
| Dow JONES (US) | 50,188.14 | 52.27 | 0.10% |
| FTSE 100 | 10,426.51 | 72.67 | 0.70% |
| HKSE | 27,266.38 | 83.23 | 0.31% |
| NASDAQ | 23,102.47 | 136.20 | -0.59% |
| Nikkei 225 | 57,650.54 | 1,286.60 | 2.28% |
| NZX 50 Index | 13,507.28 | 60.91 | 0.45% |
| S&P 500 | 6,941.81 | 23.01 | -0.33% |
| S&P/ASX 200 | 9,014.80 | 98.80 | 1.11% |
| SSE Composite Index | 4,131.98 | 3.61 | 0.09% |